638 related articles for article (PubMed ID: 35356001)
1. Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.
Ndondo AP; Eley B; Wilmshurst JM; Kakooza-Mwesige A; Giannoccaro MP; Willison HJ; Cruz PMR; Heckmann JM; Bateman K; Vincent A
Front Immunol; 2022; 13():833548. PubMed ID: 35356001
[TBL] [Abstract][Full Text] [Related]
2. Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals.
Khedr EM; Abo-Elfetoh N; Deaf E; Hassan HM; Amin MT; Soliman RK; Attia AA; Zarzour AA; Zain M; Mohamed-Hussein A; Hashem MK; Hassany SM; Aly A; Shoyb A; Saber M
Neuroepidemiology; 2021; 55(2):109-118. PubMed ID: 33631765
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated diseases involving central and peripheral nervous systems.
Leboyan A; Esselin F; Bascou AL; Duflos C; Ion I; Charif M; Castelnovo G; Carra-Dalliere C; Ayrignac X; Kerschen P; Chbicheb M; Nguyen L; Maria ATJ; Guilpain P; Carriere M; de Champfleur NM; Vincent T; Jentzer A; Labauge P; Devaux JJ; Taieb G
Eur J Neurol; 2023 Feb; 30(2):490-500. PubMed ID: 36366904
[TBL] [Abstract][Full Text] [Related]
4. Neurological Complications of Dengue Fever.
Trivedi S; Chakravarty A
Curr Neurol Neurosci Rep; 2022 Aug; 22(8):515-529. PubMed ID: 35727463
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
6. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up.
Nersesjan V; Amiri M; Lebech AM; Roed C; Mens H; Russell L; Fonsmark L; Berntsen M; Sigurdsson ST; Carlsen J; Langkilde AR; Martens P; Lund EL; Hansen K; Jespersen B; Folke MN; Meden P; Hejl AM; Wamberg C; Benros ME; Kondziella D
J Neurol; 2021 Sep; 268(9):3086-3104. PubMed ID: 33438076
[TBL] [Abstract][Full Text] [Related]
7. Current trends in autoimmunity and the nervous system.
Selmi C; Barin JG; Rose NR
J Autoimmun; 2016 Dec; 75():20-29. PubMed ID: 27545842
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune disorders affecting both the central and peripheral nervous system.
Kamm C; Zettl UK
Autoimmun Rev; 2012 Jan; 11(3):196-202. PubMed ID: 21619947
[TBL] [Abstract][Full Text] [Related]
9. Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?
Wesselingh R; Butzkueven H; Buzzard K; Tarlinton D; O'Brien TJ; Monif M
Front Immunol; 2019; 10():2066. PubMed ID: 31552027
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitor-associated central nervous system autoimmunity.
Valencia-Sanchez C; Sechi E; Dubey D; Flanagan EP; McKeon A; Pittock SJ; Zekeridou A
Eur J Neurol; 2023 Aug; 30(8):2418-2429. PubMed ID: 37151179
[TBL] [Abstract][Full Text] [Related]
11. The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa.
Ngarka L; Siewe Fodjo JN; Aly E; Masocha W; Njamnshi AK
Front Immunol; 2021; 12():803475. PubMed ID: 35095888
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions.
Englander EW
DNA Repair (Amst); 2013 Aug; 12(8):685-90. PubMed ID: 23684797
[TBL] [Abstract][Full Text] [Related]
13. Protective and Pathological Immunity during Central Nervous System Infections.
Klein RS; Hunter CA
Immunity; 2017 Jun; 46(6):891-909. PubMed ID: 28636958
[TBL] [Abstract][Full Text] [Related]
14. The contribution of thymic tolerance to central nervous system autoimmunity.
Alberti P; Handel AE
Semin Immunopathol; 2021 Feb; 43(1):135-157. PubMed ID: 33108502
[TBL] [Abstract][Full Text] [Related]
15. Post-infectious neurological disorders.
Blackburn KM; Wang C
Ther Adv Neurol Disord; 2020; 13():1756286420952901. PubMed ID: 32944082
[TBL] [Abstract][Full Text] [Related]
16. Origins and immunopathogenesis of autoimmune central nervous system disorders.
Ramanathan S; Brilot F; Irani SR; Dale RC
Nat Rev Neurol; 2023 Mar; 19(3):172-190. PubMed ID: 36788293
[TBL] [Abstract][Full Text] [Related]
17. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients.
Finsterer J; Scorza FA
J Clin Neurosci; 2021 Aug; 90():140-143. PubMed ID: 34275539
[TBL] [Abstract][Full Text] [Related]
18. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
19. Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.
Kazakos EI; Kountouras J; Polyzos SA; Deretzi G
Med Hypotheses; 2017 May; 102():33-36. PubMed ID: 28478826
[TBL] [Abstract][Full Text] [Related]
20. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.
D V; Sharma A; Kumar A; Flora SJS
ACS Chem Neurosci; 2021 Aug; 12(15):2776-2797. PubMed ID: 34260855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
